✦ LIBER ✦

Identification and evaluation of a panel of serum biomarkers for predicting response to thalidomide in multiple myeloma patients

✍ Scribed by Xiong, Qian; Ge, Feng

Book ID: 120406642
Publisher: Expert Reviews
Year: 2011
Tongue: English
Weight: 257 KB
Volume: 8
Category: Article
ISSN: 1478-9450
DOI: 10.1586/epr.11.42

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B279 Panel of Potential Proteomic Biomar

B279 Panel of Potential Proteomic Biomarkers for Predicting Response to Thalidomide in Multiple Myeloma

✍ Rajpal, R; Dowling, P; Meiller, J; Murphy, W; Murphy, P; O'Driscol, L; O'Connor, 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 125 KB

Thalidomide in combination with dexameth

Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival

✍ Philipp Schütt; Peter Ebeling; Ulrike Buttkereit; Dieter Brandhorst; Bertram Opa 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 132 KB

Prediction of ovarian cancer prognosis a

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel

✍ Oikonomopoulou, K; Li, L; Zheng, Y; Simon, I; Wolfert, R L; Valik, D; Nekulova, 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 217 KB

Predictive value of alkaline phosphatase

Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients

✍ Maurizio Zangari; Dixie Esseltine; Federica Cavallo; Rachel Neuwirth; Francesca 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Comparison of Immunofixation, Serum Free

Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma

✍ Paiva, B.; Martinez-Lopez, J.; Vidriales, M.-B.; Mateos, M.-V.; Montalban, M.-A. 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 178 KB

P130 Angiogenic factor levels in bone ma

P130 Angiogenic factor levels in bone marrow and serum of multiple myeloma patients are not applicable to predict response to chemotherapy

✍ Gy. Vadász; G. Radványi; I. Tárkányi; S. Baráth; M. Udvardy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

showed diffuse large B-cell lymphoma. She developed complete remission after treatment with 6 cycles R-CHOP (rituximab, and reduced doses of cyclophosphamide, vincristin, adriablastin, methylprednisolone). SLE became inactive and her symptoms of vasculitis resolved. ## Conclusion: We are bringing